Product Data Sheet

CDK2/4/6-IN-2

Catalog No. A54189

main product photo
CDK2/4/6-IN-2 is a selective inhibitor of cyclin-dependent kinases 2, 4, and 6, exhibiting IC50 values under 1 μM. This compound effectively inhibits cell proliferation and reduces the phosphorylation of the retinoblastoma protein at Ser807/811 in breast cancer cells. CDK2/4/6-IN-2 is suitable for research in cancer biology, particularly in studies focused on breast cancer.
Chemical Information
Catalog NumA54189
M. Wt475.56
FormulaC25H30FN9
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2531748-80-6
Synonyms
SMILESCC(N1CCN(C2=CN=C(NC3=NC=CC(C4=CC5=C(N=CN5C(C)C)C(F)=N4)=N3)C=C2)CC1)C
Biological Activity
DescriptionCDK2/4/6-IN-2 is a selective inhibitor of cyclin-dependent kinases 2, 4, and 6, exhibiting IC50 values under 1 μM. This compound effectively inhibits cell proliferation and reduces the phosphorylation of the retinoblastoma protein at Ser807/811 in breast cancer cells. CDK2/4/6-IN-2 is suitable for research in cancer biology, particularly in studies focused on breast cancer.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.